Please assess the completion status of the following clinical trial:

Trial Title: Episodic Future Thinking and Future Thinking Priming for Smoking Cessation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Smoke \>= 8 cigarettes daily~* Planning to quit in the next 14 days~* No regular use of other tobacco products~* Access to the internet~* In possession of a smartphone with text messaging capabilities~* In possession of an email address accessible at least every other day~Exclusion Criteria:~* Unable or unwilling to provide consent~* Unable to provide data to the research team after the quit date~* Current use of bupropion or varenicline~* Drinking \>= 20 alcoholic drinks per week~* Use of drugs of abuse in the past 30 days~* Living in the same household as a participant already enrolled in this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Arm I (active EFT, active FTP) (Type: EXPERIMENTAL): Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete an active episodic future thinking or active future thinking priming task once per week for 12 weeks, alternating every week between tasks.
- Arm II (active EFT, control FTP) (Type: EXPERIMENTAL): Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete an active episodic future thinking or control future thinking priming task once per week for 12 weeks, alternating every week between tasks.
- Arm III (control EFT, active FTP) (Type: EXPERIMENTAL): Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete a control episodic future thinking or active future thinking priming task once per week for 12 weeks, alternating every week between tasks.
- Arm IV (control EFT, control TFP) (Type: ACTIVE_COMPARATOR): Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete a control episodic future thinking or control future thinking priming tasks once per week for 12 weeks, alternating every week between tasks.

Based on this trial design, predict the completion outcome and termination type (if applicable).